Knowledge Center

Article / Sep 23, 2014

Quality Metrics - A Case for an FDA Dean's List

Authors:
  • Guy Villax
Source:
Pharmaceutical Technology, September 2014

The author (Guy Villax) presents arguments for an FDA Dean's List as a means to drive the right behaviors in the industry.

FDA is moving in the right direction when it looks to rank quality across pharmaceutical manufacturing sites. However quality is a matter of culture rather than metrics or compliance.

  • Read the extended version with links to references, examples and case studies here
  • Read the article in Pharmaceutical Technology  here

 

Also in the Knowledge Center

Related Content

Procurement

We partner, connect and align to shape supplier solutions that help Hovione reach its growth and objectives.

Page
Read more

Drug Substance Development

Talented people, smart processes and cutting-edge equipment – we have the perfect formula to meet all your process development and scale-up needs.

Page
Read more

History of Hovione

Hovione was established in Portugal in 1959 by Ivan Villax with his wife, Diane Villax, and two other Hungarian refugees: Nicholas de Horthy and Andrew Onody, thus forming the name HOVIONE.

Page
Read more